HealthLynked Corp. reports developments around its healthcare technology platform for patient engagement, care access, medical-record connectivity, and provider networking. Recurring updates cover the HealthLynked Network, the ARI AI health assistant, consumer and provider digital platforms, telehealth and appointment tools, and enterprise partnerships tied to payer, employer, and value-based care channels.
Company news also includes MedOfficeDirect medical-supply e-commerce activity, patent filings involving AI and patient record management, board and executive appointments, and capital-structure actions such as its completed reverse stock split. These updates frame HealthLynked as an OTCQB-traded healthcare technology issuer building digital tools for care navigation and healthcare data access.
HealthLynked Corp. (OTCQB: HLYK) announced a $3,000,000 equity investment from its Chairman and CEO, Dr. Michael Dent, reflecting his confidence in the company's future. Over the past year, HealthLynked has achieved significant milestones, including a 49% revenue increase compared to the same period in 2019, despite COVID-19's impact. Key initiatives included the launch of Cost Lynk, a COVID-19 tracker app, and the acquisition of Cura Health Management. This investment aims to support plans for a NASDAQ up-listing and enhance financial stability.
HealthLynked Corp. (OTCQB: HLYK) reported a 49% increase in revenue for the first half of 2020, totaling $2,498,450, alongside a 23% reduction in operating loss to $1,177,652. Second-quarter revenue dipped by 4% compared to 2019, while operating loss decreased by 7%. The company acquired Cura Health Management on May 18, 2020, aiming to enhance its ACO market presence. Telemedicine usage helped mitigate financial downturns during the COVID-19 pandemic, with patient revenue down only 4%.